BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Staging
7 results:

  • 1. Comparative study of braf gene mutations in ovarian serous tumors by immunohistochemistry and DNA sequencing.
    Liu YY; Wang QP; Liu FF; Zhu HT; He QZ
    J BUON; 2021; 26(3):670-676. PubMed ID: 34268919
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.
    Paner GP; Lopez-Beltran A; Sirohi D; Amin MB
    Adv Anat Pathol; 2016 Mar; 23(2):71-83. PubMed ID: 26849813
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mutational status of KRAS, NRAS, and braf in primary clear cell ovarian carcinoma.
    Zannoni GF; Improta G; Chiarello G; Pettinato A; Petrillo M; Scollo P; Scambia G; Fraggetta F
    Virchows Arch; 2014 Aug; 465(2):193-8. PubMed ID: 24889043
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome.
    Avril S; Hahn E; Specht K; Hauptmann S; Höss C; Kiechle M; Höfler H; Schmalfeldt B
    Gynecol Oncol; 2012 Dec; 127(3):516-24. PubMed ID: 23000388
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Borderline papillary serous tumor of the fimbriated end of the fallopian tube with peritoneal implants.
    Ondic O; Kalis V; Sima R
    J Obstet Gynaecol Res; 2011 Nov; 37(11):1702-5. PubMed ID: 21651651
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a braf-positive follicular variant of papillary thyroid cancer.
    Wolff EF; Hughes M; Merino MJ; Reynolds JC; Davis JL; Cochran CS; Celi FS
    Thyroid; 2010 Sep; 20(9):981-7. PubMed ID: 20718682
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Human papilloma virus (HPV) status, p16INK4a, and p53 overexpression in epithelial malignant and borderline ovarian neoplasms.
    Giordano G; Azzoni C; D'Adda T; Rocco A; Gnetti L; Froio E; Merisio C; Melpignano M
    Pathol Res Pract; 2008; 204(3):163-74. PubMed ID: 18180113
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.